Oxford Brain Diagnostics
About Oxford Brain Diagnostics
Oxford Brain Diagnostics is a healthcare AI company specializing in the early and differential diagnosis, progression tracking, and prognosis of neurodegenerative diseases. Their core technology, Cortical Disarray Measurement (CDM®), is a patented software-based analysis that utilizes standard magnetic resonance imaging (MRI) scans to detect microscopic alterations within the brain’s gray matter. This innovative approach provides an objective, quantifiable measure of neurodegeneration by analyzing the diffusion properties of water in the brain’s cortical minicolumns, which are known to be altered in conditions such as Alzheimer’s disease and Parkinson’s disease.
The CDM® technology offers insights into brain health at a cellular level, previously only accessible through post-mortem examination, enabling clinicians to identify neurodegenerative changes years before traditional symptoms manifest or standard MRI scans show macroscopic changes. Oxford Brain Diagnostics’ platform has received FDA Breakthrough Device Designation for evaluating adults at risk of Alzheimer’s Disease, and has secured FDA 510(k) clearance and UKCA self-certification, facilitating its commercial rollout in the US and UK healthcare sectors. Beyond clinical diagnosis, the technology also supports pharmaceutical and biotechnology companies in more targeted and efficient drug development and clinical trials for various neurodegenerative conditions.
Focus Areas
Business Intelligence
| Key Investors | BGF, Oxford Technology & Innovations Fund (OTIF), University of Oxford Innovation Fund (UOIF) IV, Parkwalk Advisors, RT Capital, University of Oxford, Grow London, Barossa, Fushia Investments, iHealthexpress |
| Partnerships | Caladrix (Phase 1b Trial of C-001 in Alzheimer's Disease), AbbVie (Parkinson's Disease research), INmune Bio (XPro1595 in Alzheimer's Patients), The Michael J. Fox Foundation (Parkinson's research), NeuroTherapia (Alzheimer's Phase 2 Clinical Trial), Florida Memory Treatment Centers |
| Technology | Cortical Disarray Measurement (CDM®) technology, CDM Insights software, cloud-native, AI algorithms, diffusion MRI analysis, processes standard MRI scans (1.5T and 3T), multi-cloud approach (OVHcloud and hyperscale cloud providers) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Oxford Brain Diagnostics' CDM Insights offers a revolutionary tool for early and precise assessment of brain health. It provides objective, quantifiable insights into cellular-level neurodegeneration from standard MRI scans, enabling earlier diagnosis, more informed treatment decisions, and proactive patient management. The ability to detect microstructural changes years before symptoms appear can significantly impact patient pathways, allowing for earlier intervention and personalized care, especially with the advent of new anti-amyloid Alzheimer's drugs. The comprehensive reports, including normative comparisons and longitudinal tracking, offer a deeper understanding of disease progression and response to treatment. The non-invasive, FDA-cleared, and HIPAA-compliant nature of the software, coupled with quick report turnaround times (within 12 hours), makes it a practical and valuable addition to neurological diagnostics.
CDM Insights is designed to integrate seamlessly with existing PACS systems, processing standard anatomical and diffusion MRI data in a secure cloud environment. This allows for efficient workflow and timely access to advanced diagnostic reports for clinicians. The platform is built on a multi-cloud approach, utilizing hyperscale cloud providers and OVHcloud for robust data storage and compute capabilities.
Reviews & Opinions
Videos
News, demos, and interviews about Oxford Brain Diagnostics.
Videos load interactively. If none appear, search YouTube for Oxford Brain Diagnostics →
Press & Coverage
Frequently Asked Questions
Related Companies
Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]